📰 Bioengineering Professor News
Bioengineering Professor News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bioengineering Professor. Real-time updates on events, politics, business and more.
November 9, 2023
*almost every single graf ends with “he said” or “she said” or “____ said,” combine or reword some because it’s very repetitive and distracting-JG A WSU-made machine is capable of growing cells for cancer immunotherapy and has reached new levels of development. The research for the bioreactor began with efforts by Dr. William Davis, WSU...
August 16, 2023
Due to groundbreaking work by Canadian scientists at Université de Montréal, two molecular languages at the origin of life have been efficiently recreated and mathematically evaluated.
February 23, 2023
A University of Texas at Arlington bioengineering professor is leading a state-funded project that will try to identify what T-cells are detecting in cancerous cells to better craft a personalized cancer immunotherapy.
July 15, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
July 15, 2022
Check out news from Equiva, Canvas Medical, Particle Health, Fold Health, and Nucleus Genomics.
July 14, 2022
Nucleus Genomics, cofounded by Caio Hachem, is a direct-to-consumer genetic testing platform that allows users to take control of their genetic data inexpensively.
July 14, 2022
Seed+ Funding Round Led by Seven Seven Six Nets $14 Million
June 27, 2022
An effort to create biodegradable nanoparticles that can capture images and administer medication to treat peripheral arterial disease (PAD) is being led by a bioengineer at the University of Texas at Arlington.
July 15, 2021
UTA bioengineering professor developing technique to diagnose tiny breast tumors A bioengineering professor at The University of Texas at Arlington is developing a technique to diagnose tiny breast tumors that could reduce the anxiety, uncertainty and high costs often faced by patients. Biopsy results show that about 80% of very small tumors are benign; 15% are low-grade, non-life-threatening cancers; and 5% are aggressive and invasive tumors that need immediate attention. The National Institut...